| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | SVP, Head Of Biology
2 companies
Lackner Mark is a Chief Scientific Officer at Zentalis Pharmaceuticals, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $2.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 14,368 | $1.71 | $24,590.83 | -2.7% | -19.0% | +67.9% | |
| Jan 2, 2025 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 4,411 | $3.12 | $13,762.32 | -2.3% | -54.8% | -54.3% | |
| Feb 2, 2024 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 1,585 | $11.54 | $18,290.90 | -0.8% | -4.1% | -85.0% | |
| Feb 10, 2021 | IDYA Ideaya Biosciences, Inc. | SVP, Head Of Biology | Sale+OE | 2,000 | $21.03 | $42,052.34 | -90.9% | - | - | |
| Jan 26, 2021 | IDYA Ideaya Biosciences, Inc. | SVP, Head Of Biology | Sale+OE | 2,501 | $18.46 | $46,157.91 | -75.8% | - | - | |
| Jun 17, 2020 | IDYA Ideaya Biosciences, Inc. | SVP, Head Of Biology | Sale+OE | 7,123 | $15.19 | $108,188.36 | -100% | - | - | |
| Jun 2, 2020 | IDYA Ideaya Biosciences, Inc. | SVP, Head Of Biology | Sell | 845 | $9.21 | $7,779.13 | -61.0% | - | - |